All In MedTech

FDA Clearance Tracker · K223746

Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Thermogard XP Console, Thermogard HQ Console

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Jan 13, 2023 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Jan 13, 2023

Unknown

Time to decision

30 days

Received Dec 14, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K223746
Device name
Solex 7 Intravascular Heat Exchange Catheter, Cool Line Intravascular Heat Exchange Catheter, ICY Intravascular Heat Exchange Catheter, Quattro Intravascular Heat Exchange Catheter, Thermogard XP Console, Thermogard HQ Console
Applicant location
San Jose, CA
Received
Dec 14, 2022
Decided
Jan 13, 2023
Decision
Unknown
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 870.5900
Specialty
Cardiology

Every decision under product code NCX

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code NCX. The earliest in FDA's data is K012512, decided Jun 11, 2002.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Zoll Circulation, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.